Fiji is in the grip of an HIV crisis that is now infecting its most vulnerable citizens — babies and toddlers. In 2024, at least 32 children contracted HIV through mother-to-child transmission alone, a route of infection that modern medicine has made almost entirely preventable. The president of the Fiji Medical Association put it bluntly: “If you get one baby born HIV positive, that means your system is gone.” The fact that dozens of infants are testing positive means Fiji’s public health infrastructure didn’t just falter — it collapsed. The crisis didn’t appear overnight.
It is the result of more than a decade of chronic underfunding, a methamphetamine epidemic that has torn through Fiji’s communities, and a healthcare system that lost its capacity to screen pregnant women and deliver antiretroviral treatment in time. In 2024, Fiji recorded 1,583 new HIV cases nationally, and in just the first six months of 2025, another 1,226 cases were reported. Only about 36 percent of people living with HIV in Fiji even know their status, and just 24 percent are receiving treatment. This article examines how Fiji’s healthcare system failed its children, the role of drug trafficking and dangerous injection practices, what international organizations are doing in response, and why this crisis carries lessons for government accountability worldwide.
Table of Contents
- How Are Babies and Toddlers in Fiji Getting Infected With HIV?
- The Funding Collapse That Destroyed Fiji’s HIV Prevention System
- Methamphetamine, Bluetoothing, and the Drug Epidemic Fueling HIV’s Spread
- What Is Being Done — International Response and Government Action
- Why Only 36 Percent of HIV-Positive Fijians Know Their Status
- Lessons for Government Accountability Beyond Fiji
- What Comes Next for Fiji’s Children
- Conclusion
- Frequently Asked Questions
How Are Babies and Toddlers in Fiji Getting Infected With HIV?
The primary route is mother-to-child transmission, which can occur during pregnancy, labor, delivery, or breastfeeding. When a pregnant woman living with HIV receives proper antiretroviral therapy, the risk of passing the virus to her child drops to below two percent. Without treatment, that risk jumps to between 15 and 45 percent. In Fiji, the prevention of mother-to-child transmission (PMTCT) services have been gutted by years of neglect. PMTCT is currently only available at tertiary hospitals and a handful of sub-district facilities, meaning women in rural areas and outer islands often go through entire pregnancies without being tested. Dr.
Rachel Devi, head of Fiji’s Family Health Unit, confirmed that more than 20 mother-to-child transmission cases were recorded in 2024 alone. Independent reporting places the figure higher, at 32 confirmed cases linked to vertical transmission. Staff shortages, limited training, and a lack of basic medical supplies at clinics have all been cited as barriers to delivering adequate PMTCT care. In many cases, women are simply not being screened during prenatal visits, and by the time a diagnosis comes, it is too late to prevent transmission to the newborn. The contrast with functioning health systems is stark. Countries like Thailand and Cuba have achieved WHO-validated elimination of mother-to-child HIV transmission. Fiji, with a population of under one million, should be able to achieve the same — but only if the political will and funding materialize to rebuild what was lost.
The Funding Collapse That Destroyed Fiji’s HIV Prevention System
The roots of this crisis trace back to a catastrophic drop in HIV and AIDS funding. Between 2011 and 2012, Fiji’s HIV and AIDS budget plummeted from US$2.3 million to just US$400,000 — a reduction of more than 80 percent in a single year. The consequences were predictable and devastating. Media campaigns for HIV awareness stopped. Prevention programs targeting high-risk populations were deprioritized or shut down entirely. Health workers trained in PMTCT moved on or retired without being replaced.
However, funding cuts alone don’t explain the full picture. Even as international health organizations flagged rising HIV numbers in subsequent years, Fiji’s government was slow to respond. The country’s broader public health apparatus was strained by competing crises, including COVID-19 recovery and natural disasters. HIV simply fell off the political radar. It wasn’t until January 2025 that the Ministry of Health formally declared a national HIV outbreak and established a dedicated taskforce, by which point the virus had already spread through drug-using communities and into the general population at alarming rates. If Fiji’s government had maintained even modest funding levels and kept routine HIV screening embedded in prenatal care throughout the 2010s, the infant infection numbers seen in 2024 would likely never have occurred. This is a textbook case of how defunding public health doesn’t save money — it creates far more expensive crises down the road.
Methamphetamine, Bluetoothing, and the Drug Epidemic Fueling HIV’s Spread
Fiji has become a transit point for international methamphetamine trafficking, and local drug use has surged as a result. On the streets, meth-filled syringes sell for as little as 10 Fijian dollars. A practice known as “bluetoothing” — where one user injects methamphetamine, withdraws their drug-rich blood, and injects it into a second person, who repeats the process for a third — has been widely reported as a major driver of HIV transmission. The practice saves money but guarantees the sharing of blood between multiple users.
Reports indicate that children as young as 13 have contracted HIV through intravenous drug use. The Washington Post reported in February 2026 on how Mexican and Asian drug cartels have used Fiji’s remote geography and limited law enforcement capacity to establish trafficking routes, flooding the islands with cheap methamphetamine. The downstream health consequences are now impossible to ignore. It should be noted that more recent WHO research has found limited direct evidence of bluetoothing in practice, suggesting the problem may be driven more broadly by needle sharing and unsafe injection environments rather than this single dramatic practice. Regardless of the exact mechanism, the underlying issue is clear: Fiji lacks sufficient harm reduction infrastructure, including needle exchange programs and safe injection sites, to blunt the epidemic’s spread among people who inject drugs.
What Is Being Done — International Response and Government Action
After years of inaction, both the Fijian government and international partners have scrambled to respond. In January 2025, Fiji declared a national HIV outbreak and authorized 10 million Fijian dollars (approximately £3.3 million) for treatment, testing, and public awareness. Australia contributed NZ$5.9 million and has invested more than NZ$56 million in a broader Pacific-wide HIV response program. The United Nations Development Programme has delivered critical medical supplies, and WHO, UNICEF, and UNAIDS have launched a regional roadmap for “triple elimination” of mother-to-child transmission of HIV, syphilis, and hepatitis B. The tradeoff Fiji faces is between speed and sustainability.
Emergency funding can purchase antiretroviral drugs and rapid test kits immediately, but rebuilding the healthcare workforce — training nurses in PMTCT protocols, staffing rural clinics, and integrating HIV screening into routine prenatal care — takes years. If Fiji treats this as a one-time emergency rather than a systemic failure requiring sustained investment, the crisis will recur. The country has been down this road before: robust funding in 2011 was followed by near-total defunding in 2012, and the results speak for themselves. There is also the question of stigma. UNAIDS has specifically called for a non-discriminatory approach to Fiji’s HIV response. Criminalizing drug use and shaming people living with HIV drives the epidemic underground, making it harder to test, treat, and ultimately contain.
Why Only 36 Percent of HIV-Positive Fijians Know Their Status
One of the most alarming statistics in Fiji’s outbreak is that roughly two-thirds of people living with HIV are unaware they are infected. In a country with an estimated 5,900 to 6,100 people living with HIV — a figure that has grown elevenfold in just ten years — this means thousands of individuals are unknowingly transmitting the virus to sexual partners, needle-sharing contacts, and in the case of pregnant women, their unborn children. The testing gap is driven by several factors. Fiji has limited laboratory capacity outside of its main urban centers. HIV testing is not systematically integrated into routine healthcare visits, meaning people who don’t specifically seek testing are unlikely to receive it.
Stigma plays a major role as well — in a small island society, the social consequences of an HIV diagnosis can be severe, discouraging people from getting tested even when services are available. This is the most dangerous limitation of Fiji’s current response. You cannot treat what you cannot find. Until testing coverage reaches a critical mass — the WHO benchmark is 95 percent of people living with HIV knowing their status — the epidemic will continue to outpace containment efforts. For infants, this means the window to administer prophylactic treatment at birth is missed entirely when a mother’s HIV status is unknown.
Lessons for Government Accountability Beyond Fiji
Fiji’s HIV crisis is a case study in what happens when governments defund public health infrastructure and fail to maintain basic disease surveillance. The pattern is not unique to the Pacific. In the United States, state-level cuts to public health departments have been linked to delayed responses to outbreaks ranging from hepatitis A to syphilis.
The Trump administration’s proposed restructuring of federal health agencies, including reductions at the CDC and USAID, has raised concerns among public health experts that similar gaps in disease monitoring could emerge domestically and in countries that depend on American foreign aid for HIV prevention programs. The core lesson is straightforward: prevention is cheaper than crisis response. Every dollar not spent on routine prenatal HIV screening in Fiji is now being spent tenfold on emergency antiretroviral treatment for infected infants and their mothers. Governments that treat public health funding as discretionary spending eventually learn this lesson the hard way — and it is their most vulnerable citizens, including newborns, who pay the price.
What Comes Next for Fiji’s Children
Fiji’s government and its international partners are now pursuing a strategy to expand PMTCT services beyond tertiary hospitals and integrate HIV screening into all maternal and child health programs. If executed properly, this could dramatically reduce the number of babies born with HIV within the next two to three years. The WHO’s triple elimination framework provides a tested roadmap, and countries with far fewer resources than Fiji have achieved it.
But success depends on sustained political commitment and funding — not just during the current emergency, but for years afterward. The children already born with HIV in Fiji will require lifelong antiretroviral therapy, consistent access to healthcare, and protection from the social stigma that still surrounds the disease. Their futures depend on whether Fiji’s leaders treat this crisis as a turning point or simply another news cycle to weather.
Conclusion
Fiji’s HIV outbreak has exposed a catastrophic failure of public health governance. Babies and toddlers are being born with a virus that is almost entirely preventable through routine screening and treatment — a failure made possible by years of funding cuts, healthcare workforce attrition, and political neglect. The methamphetamine epidemic and associated injection practices have accelerated HIV’s spread into the general population, but it is the collapse of basic maternal health services that explains why infants are now bearing the consequences.
The path forward requires Fiji to rebuild its PMTCT infrastructure, expand testing to reach the majority of its population that remains undiagnosed, and sustain funding levels well beyond the current emergency. For observers in other countries, including the United States, Fiji’s crisis is a warning about the real-world cost of defunding public health. Prevention programs are invisible when they work, and their absence is only noticed when babies start testing positive.
Frequently Asked Questions
How many babies were born HIV-positive in Fiji in 2024?
At least 32 cases of mother-to-child HIV transmission were recorded in 2024, though some reports place the number of total child infections at 41.
What is bluetoothing and how does it spread HIV?
Bluetoothing is a reported practice where intravenous drug users inject methamphetamine, then withdraw their drug-laden blood and inject it into another person to share the high. This direct blood-to-blood contact creates an extremely high risk of HIV transmission, though recent WHO research has found limited direct evidence of the practice at scale.
Can mother-to-child HIV transmission be prevented?
Yes. With proper antiretroviral therapy administered during pregnancy and after birth, the risk of mother-to-child transmission drops to below two percent. Multiple countries have achieved WHO-certified elimination of this transmission route.
How many people in Fiji are living with HIV?
Estimates range from 5,900 to 6,100 people — roughly an elevenfold increase over the past decade. Only about 36 percent of those infected are aware of their status.
What is the Fijian government doing about the HIV crisis?
In January 2025, Fiji declared a national HIV outbreak and allocated 10 million Fijian dollars for response efforts. Australia and international organizations including UNDP, WHO, and UNAIDS have also provided funding and medical supplies.
Why did Fiji’s HIV prevention system fail?
HIV and AIDS funding dropped from US$2.3 million in 2011 to just US$400,000 in 2012. This led to the collapse of prevention programs, awareness campaigns, and healthcare worker training, creating the conditions for the current outbreak.